Desmuramylpeptide, a NOD2 agonist, enhanced immune response and parasite clearance in <i>Leishmania donovani</i> infection
Overall, the study highlights NOD2 as a critical mediator of immune modulation during <i>Leishmania</i> infection, suggesting its potential as a pharmacological target for host-directed immune intervention.
Authors
- Sukhbir Kaur (ORCID: https://orcid.org/0000-0001-9071-7950)
- Aarzoo Kamboj
- Sandeep Kaur
- Shivani Thakur (ORCID: https://orcid.org/0009-0002-5060-8236)
- Deepak B. Salunke
Institutions
- National Institute of Pharmaceutical Education and Research (IN)
- Panjab University (IN)
Publication Details
- Journal
- Future Medicinal Chemistry
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1080/17568919.2025.2559574
- Citations
- 1
- Primary Topic
- Research on Leishmaniasis Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.88